Coralie Poncet
Brussels, BRU, Belgium
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 44 publications
Alkaline Phosphatase and Prostate-specific Antigen Response in Metastatic Castration-resistant Prostate Cancer Treated with Enzalutamide Alone or in Combination with Radium-223: Ad Hoc Analysis of the PEACE-3 Consortium Trial.
Journal: European urology oncology
Published: March 17, 2026
Final overall survival results from EORTC 1333/PEACE-3 trial of enzalutamide plus radium-223 in metastatic castration-resistant prostate cancer.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: February 04, 2026
ASO Visual Abstract: The Value of Ultrasound in Patients with T1-T2 Breast Cancer with No Palpable Lymph Nodes Enrolled in the EORTC 10981-22023 AMAROS Trial.
Journal: Annals of surgical oncology
Published: January 24, 2026
A plain language summary of the EORTC 1333/PEACE-3 study of enzalutamide alone vs enzalutamide plus radium-223 in patients with metastatic castrationresistant prostate cancer (mCRPC) and bone metastases.
Journal: Future oncology (London, England)
Published: November 28, 2025
Belimumab use in paediatric-onset systemic lupus erythematosus: a status report in France from a retrospective multicentre descriptive study.
Journal: Rheumatology (Oxford, England)
Published: November 09, 2025
Transcriptomic Insights into Lobular Breast Cancer Biology and Patient Outcomes: Analysis of the MINDACT Clinical Trial.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: October 16, 2025
The Value of Ultrasound in Patients with T1-T2 Breast Cancer with No Palpable Lymph Nodes Enrolled in the EORTC 10981-22023 AMAROS Trial.
Journal: Annals of surgical oncology
Published: September 10, 2025
Enzalutamide plus radium-223 in metastatic castration-resistant prostate cancer: results of the EORTC 1333/PEACE-3 trial.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: April 12, 2025
Survival outcomes for patients with invasive lobular cancer by MammaPrint: Results from the MINDACT phase III trial.
Journal: European journal of cancer (Oxford, England : 1990)
Published: November 02, 2024
Prognostication and treatment predictions for estrogen receptor positive early-stage breast cancer: incorporating the 70-gene signature into the PREDICT prognostication model.
Journal: Breast (Edinburgh, Scotland)
Published: September 18, 2024
Machine learning-based spatial characterization of tumor-immune microenvironment in the EORTC 10994/BIG 1-00 early breast cancer trial.
Journal: NPJ breast cancer
Published: June 23, 2024
Locoregional Breast Cancer Recurrence in the European Organisation for Research and Treatment of Cancer 10041/BIG 03-04 MINDACT Trial: Analysis of Risk Factors Including the 70-Gene Signature.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: January 19, 2024
Last Updated: 09/26/2026